Multiple Myeloma Management 对比 HealthTree 的使用情况和统计数据
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
HealthTree is the one, easy-to-access app to learn about your blood cancer, find a community and unite with researchers to discover lifesaving treatments for diseases.
The HealthTree app brings all the features the HealthTree Foundation has to offer, including:
- Track your labs, genetics, and more from all of your facilities in one convenient place
- Find life-saving clinical trials perfect for you automatically
- Gain free access to step-by-step patient guides
- Get on-demand help from our patient navigators
- Find a free patient coach for all your needs
- Find a community, ask questions and share your story with others
- Learn from over 200+ specialists
- Join events, chapters and listen to expert podcasts
- Stay up-to-date on disease news and breakthroughs
- Participate in life-saving research
- Apple 应用商店
- 免费
- 健康与健身
商店排名
- -
Multiple Myeloma Management VS. 
HealthTree十二月 19, 2024